Amesite Inc (AMST) Stock Analysis
Verdict: AVOID
Cash-rich balance sheet buys time, but a 16.8x P/S valuation on collapsing revenue makes this a speculative 'dead cat bounce' candidate.
Investment score: 32/100
Analysis as of
Is Amesite Inc stock worth reviewing? The TradeMates thesis
High-risk micro-cap with terminal revenue decline but significant insider buying activity at levels above the current price.
7-factor investment score
- Valuation: 15/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 20/100 (weight 15%)
- Insider Sentiment: 85/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
Amesite Inc opportunities and risks
What speaks for AMST
- Cash-to-Market Cap Ratio
What speaks against AMST
- Terminal Revenue Decline
Peers and competitors
- PCSV
- PCST
- ASPU
- LTRE
- AMBO
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| AMST | n/a | 16.8x | n/a | 59.3% | -871.9% | -36.4% |
| PCST | n/a | 1.6x | n/a | 99.9% | -257.6% | -141.5% |
| ASPU | 1.4x | 0.2x | 2.6x | 71.2% | 13.7% | 21.4% |
| LTRE | n/a | 0.1x | n/a | 43.0% | -3.2% | -28.2% |
| AMBO | 2.0x | 0.0x | 6.5x | 55.5% | 30.6% | 94.6% |
| Peer median | n/a | 0.1x | n/a | 63.4% | 5.3% | -3.4% |
Frequently asked questions about Amesite Inc (AMST)
Is AMST stock a good investment?
The TradeMates model rates Amesite Inc as AVOID with an investment score of 32/100. High-risk micro-cap with terminal revenue decline but significant insider buying activity at levels above the current price. This is algorithmic model output, not personal investment advice.
Is AMST stock a buy?
The TradeMates model verdict for AMST is AVOID with an investment score of 32/100. Treat this as a model signal to review, not a personal buy recommendation.